Both in Biotechnology
Kalaris Therapeutics vs Cardiff Oncology
Over the past year KLRS returned −52.8% and CRDF returned −66.3%; their daily moves had a correlation of 0.11.
KLRS −52.8% CRDF −66.3%Growth of $1, one year, split-adjusted
| Metric | KLRS | CRDF |
|---|---|---|
| Price | $2.36 | $0.7553 |
| Market cap | $56.2M | $58.8M |
| Today | +16.83% | −13.07% |
| 1 month | −7.8% | −30.7% |
| 6 months | −54.2% | −52.8% |
| Year to date | −72.0% | −73.1% |
| 1 year | −49.9% | −66.0% |
| Revenue growth (YoY) | — | −14.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −8882.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 115.7× |
| Net cash | $93.5M | $34.5M |
| Dividend yield | — | — |
| Volatility (60d) | 65.4% | 76.0% |
| Short % of float | 5.4% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).